This 23-year-old wunderkind seeks a new age for old age
Laura Deming wants to make this perfectly clear: Your startup doesn't need to be called an "aging" company to get into her new accelerator.
If you're a driven CEO, that's a start. If you've got some good science, all the better. But if there's a definable milestone among the ambiguity of age-related diseases, she said, that's where her Age1 accelerator can help.
"Is there something we can specifically help them with — it's not just housing but getting to inflection points," Deming said.
The…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news